Trial Profile
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 17 Mar 2016
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Abdominal pain; Diarrhoea; Irritable bowel syndrome
- Focus Therapeutic Use
- 29 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 09 Jun 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 09 Jun 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.